|
|
Guidance/Advisory Criteria — Conditions |
Hypertrophic Cardiomyopathy |
|
Hypertrophic cardiomyopathy is a complex disease characterized by marked morphologic, genetic, and prognostic heterogeneity. Some individuals experience a benign and stable clinical course, while in others the disease is characterized by progressive symptoms. For some individuals, sudden death is the first definitive manifestation of the disease.
Certification/Recertification — Hypertrophic Cardiomyopathy
Waiting period
If you note an enlarged heart in a driver, you should not certify the driver until evaluation by a cardiovascular specialist who understands the functions and demands of commercial driving to confirm or rule out a diagnosis of hypertrophic cardiomyopathy.
Decision
Recommend to certify if:
Not applicable.
Recommend not to certify if:
The driver has a diagnosis of hypertrophic cardiomyopathy.
Monitoring/Testing
Not applicable.
Follow-up
Not applicable.
Cardiomyopathies and Congestive Heart Failure Recommendation Table (PDF)
|